Back to results
CompletedPhase 3

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

NCT00090116

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pivotal Research Centers

Peoria, Arizona, United States

+33 additional locations

View on ClinicalTrials.gov
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease — TrialFind